Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group

1997307 citationsJournal Article

Authors

Dan Zimbroff · Loma Linda University Medical Center

John M. Kane

Abstract

Sertindole is a new antipsychotic agent effective for the treatment of both the positive and negative symptoms of schizophrenia, with motor side effects that are indistinguishable from those associated with placebo.

Topics & Keywords

Schizophrenia research and treatment Tryptophan and brain disorders Bipolar Disorder and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Psychiatry

Volume 154, Issue 6, pp. 782-791

DOI: 10.1176/ajp.154.6.782

Field-Weighted Citation Impact: 21.65